Pre-visit Companion Brief: a primary care AI-assisted check for depression and anxiety
Official title: Validation of an Artificial Intelligence (AI)-Powered Clinical Decision Support System for Anxiety and Depression in Primary Care Settings
Run by Singula Health, Inc. · NCT07834684 · Data updated 2026-11-12
This pilot tests an AI-powered pre-visit assessment that creates a concise Companion Brief for clinicians to help identify depression and anxiety during routine primary care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Singula Health, Inc. Industry-sponsored |
| Locations | 2 sites (Brentwood, New York and 1 other locations) |
| Status | Recruiting |
| Started | July 13, 2026 |
| Main results expected | December 2026 |
| Study ends | January 2027 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07834684 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older who are scheduled for a routine primary care visit, able to read English, and have access to a personal device to complete the survey.
✕Probably not a fit
Patients who do not engage with the pre-visit assessment or whose data cannot be effectively translated into a usable Companion Brief may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-arm, observational pilot in primary care that examines a clinical decision support system designed to summarize patient-reported mental health information into a Companion Brief for clinicians. After a patient completes a pre-visit, validated screening measures and questions are processed by an automated pipeline to generate a draft Companion Brief, which the Principal Investigator reviews before sharing with the clinician. The goal is to assess feasibility, reliability of brief generation, and clinician and patient acceptance of the workflow in real-world settings. The study refrains from directing treatment and focuses on feasibility, operational performance, and user feedback to inform future development. Findings will guide potential next steps for technical and procedural refinements.
Why it matters
Potential benefit: If successful, it could streamline pre-visit information gathering and help clinicians quickly contextualize mental health symptoms during primary care visits.
How similar studies have gone: Previous similar workflows using AI-generated summaries in primary care have shown feasibility but require further validation in real-world settings, making this pilot a novel feasibility assessment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult, aged 18 years or older at the time of consent. * Scheduled for a routine, non-urgent primary care visit at a participating practice. * Able to read and understand English at a level sufficient to complete the electronic informed consent and Survey 0.1 independently. * Has personal-device access to complete the survey (smartphone, tablet, or computer with internet). * Capable of providing informed consent. Exclusion Criteria: * Non-English-speaking, defined as inability to read English at a level sufficient to complete electronic informed consent and the survey independently. * Visually impaired to a degree that prevents independent reading of an electronic consent form on a personal device, without specialized assistive technology beyond standard mobile-device accessibility features. * Unable to read for any reason (literacy, cognitive impairment, or other). * Presenting with an acute psychiatric emergency or in acute crisis at the time of the scheduled visit, as identified by clinic staff during routine check-in. * Patient is a known minor at the time of scheduling (under 18 years). * Patient or clinician declines participation.
Where it's running
-
WestDocs Concierge
Mount Kisco, New York, United States Recruiting -
Morris Medical Office
Brentwood, New York, United States Completed
Study contacts
- Principal investigator: Marc S Lener, MD — Singula Health, Inc.
- Study coordinator: Marc S Lener, MD
- Email: marc.lener@singulahealth.com
- Phone: (240) 389-2381
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mobile CBT for mood after a stroke
A mobile CBT app called Maya is tested to see if it helps adults recently recovering from stroke manage depression and anxiety during rehab.
-
Group-based ACT for psychological distress in young people
Researchers are testing whether group-based ACT helps 16-25 year olds with depression or anxiety more than the usual individual therapy.
-
Behavioral health collaborative care for family members of ICU survivors in the Post-ICU clinic pilot
This pilot tests a telehealth-based behavioral health program using the NeuroFlow app for family members of ICU survivors to try to reduce anxiety, depression, and PTSD symptoms.
-
No Time to Wait — Single-Session Growth-Mindset Program for Teens
This project will try a single-session online growth-mindset program to help Hong Kong adolescents aged 12–17 who have elevated depression or anxiety symptoms.
-
Behavioral health collaborative care for people recovering after ICU
This trial will test whether a coordinated behavioral health program using a digital app, coaching, and psychiatric support helps ICU survivors reduce anxiety, depression, and PTSD symptoms.
-
Home-based inspiratory muscle training to lower dementia risk in older adults
This study will test whether an 8-week, daily home inspiratory breathing program can lower blood pressure and improve thinking, mood, and sleep in adults aged 60–80 who have risk factors for dementia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.